Highlights in pathogenesis of vitiligo
Open Access
- 1 January 2015
- journal article
- review article
- Published by Baishideng Publishing Group Inc. in World Journal of Clinical Cases
- Vol. 3 (3), 221-30
- https://doi.org/10.12998/wjcc.v3.i3.221
Abstract
Vitiligo is a common pigmentary disorder. Many studies across decades and all over the world have attempted to illustrate the pathogenesis behind it; however, the pathogenesis of vitiligo remains elusive. This review article, we present the findings behind the most and updated theories behind this psychologically debilitating and disfiguring disease. The discussion begun with the role of genetic predisposition followed by neural theory first proposed in the 1950s. We highlight the autoimmune hypothesis, followed by the reactive oxygen species model, zinc-α2-glycoprotein deficiency hypothesis, viral theory, intrinsic theory and biochemical, molecular and cellular alterations accounting for loss of functioning melanocytes in vitiligo. Many theories were elaborated to clarify vitiligo pathogenesis. It is a multifactorial disease involving the interplay of several factors. Future research is needed to clarify the interaction of these factors for better understanding of vitiligo pathogenesis and subsequent successful treatment.Keywords
This publication has 130 references indexed in Scilit:
- Comprehensive Association Analysis of Candidate Genes for Generalized Vitiligo Supports XBP1, FOXP3, and TSLPJournal of Investigative Dermatology, 2011
- Genome-Wide Association Study of Generalized Vitiligo in an Isolated European Founder Population Identifies SMOC2, in Close Proximity to IDDM8Journal of Investigative Dermatology, 2010
- Frontiers and controversies in the pathobiology of vitiligo: separating the wheat from the chaffExperimental Dermatology, 2009
- The RNase Rny1p cleaves tRNAs and promotes cell death during oxidative stress in Saccharomyces cerevisiaeThe Journal of cell biology, 2009
- The developmentally-regulated Smoc2 gene is repressed by aryl-hydrocarbon receptor (Ahr) signalingGene, 2009
- Therapeutic interventions for vitiligoJournal of the American Academy of Dermatology, 2008
- Lineage-specific silencing of human IL-10 gene expression by promoter methylation in cervical cancer cellsEuropean Journal of Cancer, 2008
- A systematic review of natural health product treatment for vitiligoBMC Dermatology, 2008
- Current state of vitiligo therapy – evidence‐based analysis of the literatureJDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2007
- Topical tacrolimus therapy for vitiligo: therapeutic responses and skin messenger RNA expression of proinflammatory cytokinesJournal of the American Academy of Dermatology, 2004